Medicinova

MNOVNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$71.863 M

$1.46 +0.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Medicinova (MNOV) has a market capitalization of $71.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$409.7K

#3519 by revenue

Earnings

$12.0M

#1999 by earnings

Shares outstanding

49,221,246

Latest filing cover page

P/E ratio

6.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#305Tonix PharmaceuticalsTNXP$79.0M
#306Cumberland PharmaceuticalsCPIX$75.5M
#307MedicinovaMNOV$71.9M
#308Rani TherapeuticsRANI$71.7M
#309Acrivon TherapeuticsACRV$67.3M

What if Medicinova were worth as much as…

Open the what-if tool →

Gold $28.2T

$573,672.47

Per share 392,926× higher

Bitcoin $1.53T

$31,040.42

Per share 21,261× higher

Apple $5.02T

$101,902.80

Per share 69,796× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Medicinova are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.